1. Home
  2. BCTX vs NBY Comparison

BCTX vs NBY Comparison

Compare BCTX & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$4.02

Market Cap

28.8M

Sector

Health Care

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.95

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCTX
NBY
Founded
2014
2000
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.8M
31.6M
IPO Year
2025
2007

Fundamental Metrics

Financial Performance
Metric
BCTX
NBY
Price
$4.02
$1.95
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$40.00
N/A
AVG Volume (30 Days)
134.9K
488.1K
Earning Date
03-10-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.42
EPS
N/A
0.76
Revenue
N/A
$370,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$380.95
N/A
P/E Ratio
N/A
$2.57
Revenue Growth
N/A
N/A
52 Week Low
$0.61
$0.43
52 Week High
$14.68
$19.95

Technical Indicators

Market Signals
Indicator
BCTX
NBY
Relative Strength Index (RSI) 45.11 57.82
Support Level $3.66 $1.01
Resistance Level $4.51 $2.52
Average True Range (ATR) 0.27 0.26
MACD 0.00 0.11
Stochastic Oscillator 20.83 96.45

Price Performance

Historical Comparison
BCTX
NBY

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: